Health ❯ Healthcare ❯ Cardiology
Risk Factors HFpEF Risks Treatment Options Artificial Intelligence Innovative Treatments Patient Stories Preventive Measures Arrhythmias Gene Therapy Cardiovascular Events Fluid Retention Indicators Immune-Fibroblast Interaction Artificial Heart Mortality Rates Preventive Strategies Patient Outcomes Genetic Variants Clinical Trials GLP-1 Medications Warning Signs Symptoms Quality of Life Heart Transplantation Obesity Metrics Protein Research Monitoring Devices Vericiguat Risk Assessment Patient Education Social Determinants of Health Hospitalization Risk Reduction Medication Adherence Dapagliflozin Inflammation Biomarkers Carotid Ultrasound Drug Treatments LVAD Devices Treatment Guidelines Recovery Mechanisms Chronic Insomnia AI in Cardiology Patient Management Biventricular Heart Failure Finerenone Management Strategies Cardiac Regeneration Ejection Fraction Atrial Fibrillation Remote Monitoring Heart Failure Treatment Reduced Ejection Fraction HfpEF Digoxin Symptoms and Treatment Transplant Surgery Wearable Technology Melatonin Use
The Nature Medicine analysis suggests genetic testing could let doctors prevent heart failure in high-risk patients before symptoms appear.
